> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Surveillance mammography beyond 5 years and advanced second breast cancer in older women
- URL: https://www.coios.me/surveillance-mammography-beyond-5-years-and-advanced-second/
- Published: 2026-11-07T13:08:14.000Z
- Updated: 2026-11-08T07:06:56.000Z
- Description: In 9,888 older breast cancer survivors, continued mammography after 5 years was not linked to fewer advanced second primary cancers.
- Author: Daniel Ryan
- Tags: Health today, Cancer, United States, #peer-reviewed, #refines, #item, #source-2026-11, #score-68

This study examined continued surveillance mammography and second primary breast cancer stage in older breast cancer survivors. This US retrospective cohort included 9,888 women with non-metastatic breast cancer diagnosed at 67 or older in 2004–2008\. All had a surveillance mammogram about 5 years after diagnosis, and 80.3% were continuing surveillance at cohort entry. Cause-specific hazard models with inverse probability of treatment weighting estimated stage-specific risk, with follow-up to December 2021\. Advanced second primary cancer reached 1.65% with continued surveillance and 2.15% without (hazard ratio 0.76, 95% CI 0.46–1.26). Findings were similar by hormone receptor status, but advanced second cancers were rare and the confidence interval was wide.

*Why it is interesting: Surveillance mammography is common among older survivors, yet its benefit at this age is uncertain. Here the absolute risk of advanced second cancer was low whether or not women continued surveillance.*

Source

[JAMA Internal Medicine, 2 November 2026](https://doi.org/10.1001/jamainternmed.2026.5465?ref=coios.me)

Paper

Surveillance Mammography and Second Primary Breast Cancer Diagnosis Among Older Women With a History of Breast Cancer

Authors

Richman IB, Long JB, Lindsay ME, Sheffrin M, Berger ER

DOI

10.1001/jamainternmed.2026.5465

Type

Peer-reviewed article

Design

Retrospective longitudinal cohort, SEER-Medicare, 9888 women aged 67+ with non-metastatic breast cancer diagnosed 2004-2008, followed to December 2021, IPTW cause-specific hazard models

Verdict

Refines prior evidence

Driver

[Cancer](https://www.coios.me/d-cancer/)

Free full text

[Free copy in a repository (submitted manuscript)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13728955/?ref=coios.me)